secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001628280-24-007032
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q4/FY2023 revenue up 7.7% to $3.2B, net loss $678.9M from goodwill impairment; guides 2024
--------------------------------------------------------------------------------

- FY2023 net revenue $3,200.2M (+7.7% YoY); net loss $678.9M vs $69.3M profit, driven by $830.8M pretax goodwill impairment.
- Q4 net revenue $858.2M (+10%); adjusted EBITDA $204.6M (+40.2%).
- FY2023 adjusted EBITDA $670.8M (+13%); free cash flow $143.2M vs ($17.6M) prior year.
- Initial FY2024 guidance: net revenue $3.25-3.35B, adjusted EBITDA $650-710M, free cash flow $150-180M.
- Leverage ratio improved to 3.16x from 3.69x year-end 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828024007032/0001628280-24-007032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828024007032/ahco-20240227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-007032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer